New drug industry-funded research found that Part B drug administration continues rising at 340B hospitals and falling at other hospitals and physician offices.
Thirty-five percent of drugs paid for by Medicare Part B in 2021 were administered in 340B hospital outpatient departments, up [...] …
Retail prescription drug spending rose by 7.8% in 2021, as COVID-19 eased and patients got care they had been putting off, CMS says.
Retail prescription drug spending in the U.S. shot up 7.8% to $378 billion in 2021, more than double the 3.7% [...] …
A federal judge in Little Rock, Ark., held that the state's novel 340B anti-discrimination law is not preempted by federal laws.
As we reported on deadline on Tuesday, a federal district court ruled this week that Arkansas’ novel 340B antidiscrimination law [...] …
Five congressional Democrats signed on as co-sponsors to a bill that would bar drugmaker restrictions on 340B contract pharmacy arrangements.
The 117th Congress appears destined to end without further action on the 340B program. The House and Senate are on [...] …
Avita’s CEO Michael Yount and Chief Advocacy Officer Glen Pietrandoni discuss why 340B advocacy is so important and what Avita [...] …
The first quarter 2023 registration period for covered entity enrollment in 340B will begin Jan. 1 and end Jan. 17.
The U.S. Health Resources and Services Administration has slightly adjusted the dates of the first of four periods in 2023 [...] …
Drugmaker Biogen recently added a third drug to its 340B contract pharmacy restrictions for hospitals.
Biopharmaceutical manufacturer Biogen yesterday became the 19th prescription drug company to announce conditions on 340B pricing when covered entities contract [...] …
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
A federal district judge ruled yesterday that Arkansas’s novel 340B anti-discrimination law is not preempted by the 340B statute nor [...] …
A bill that would enact contract pharmacy protections in Michigan has garnered renewed attention from 340B supporters and critics, alike, in the final days before the state’s legislature is set to recess for the summer.
The Michigan Senate has defeated legislation that hospitals say would have removed language from a nearly year-old state law that [...] …
Ex-U.S. Rep. Henry Waxman (D-Calif.) says in a Health Affairs commentary that criticism of the drug discount program often “reflect[s] a misunderstanding of Congress’ intent.”
Henry Waxman, a California Democrat who was one of the original sponsors of the 340B law when it was created [...] …
*Sign up for news summaries and alerts from 340B Report
Copyright © 2025 340B Report, LLC
Reproduction of material from any 340B Report page without written permission is strictly prohibited.
